Sponsor Pipeline

Guiying Wang Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07337551 Gossypol Acetate + FOLFIRI + Bev in mCRC With TP53-Mutant and LRPPRC Positive Patients With Metastatic Colorectal Cancer Who Were TP53-mutant and LRPPRC-positive and Had Previously Failed Prior First-line Treatment Not Yet Recruiting
Disease Areas
Colorectal Cancer (1)
Get alerts when Guiying Wang's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free